Free Trial

Surrozen (SRZNW) Competitors

$0.02 0.00 (-12.99%)
As of 03:56 PM Eastern
This is a fair market value price provided by Massive. Learn more.

SRZNW vs. AIMDW, ALVOW, ARAV, ACABW, and RNA

Should you buy Surrozen stock or one of its competitors? MarketBeat compares Surrozen with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Surrozen include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Avidity Biosciences (RNA). These companies are all part of the "pharmaceutical products" industry.

How does Surrozen compare to Ainos?

Surrozen (NASDAQ:SRZNW) and Ainos (NASDAQ:AIMDW) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, risk and dividends.

In the previous week, Surrozen and Surrozen both had 1 articles in the media. Surrozen's average media sentiment score of 1.89 equaled Ainos'average media sentiment score.

Company Overall Sentiment
Surrozen Very Positive
Ainos Very Positive

Company Net Margins Return on Equity Return on Assets
SurrozenN/A N/A N/A
Ainos N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Surrozen$7.49MN/AN/AN/AN/A
Ainos$124.16KN/AN/AN/AN/A

Summary

Surrozen beats Ainos on 1 of the 1 factors compared between the two stocks.

How does Surrozen compare to Alvotech?

Surrozen (NASDAQ:SRZNW) and Alvotech (NASDAQ:ALVOW) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, valuation, analyst recommendations, media sentiment, earnings, risk and institutional ownership.

Company Net Margins Return on Equity Return on Assets
SurrozenN/A N/A N/A
Alvotech N/A N/A N/A

In the previous week, Alvotech had 1 more articles in the media than Surrozen. MarketBeat recorded 2 mentions for Alvotech and 1 mentions for Surrozen. Surrozen's average media sentiment score of 1.89 beat Alvotech's score of 1.44 indicating that Surrozen is being referred to more favorably in the media.

Company Overall Sentiment
Surrozen Very Positive
Alvotech Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Surrozen$7.49MN/AN/AN/AN/A
Alvotech$586.32MN/AN/AN/AN/A

Summary

Alvotech beats Surrozen on 2 of the 3 factors compared between the two stocks.

How does Surrozen compare to Aravive?

Aravive (NASDAQ:ARAV) and Surrozen (NASDAQ:SRZNW) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, risk, dividends, valuation and earnings.

35.8% of Aravive shares are held by institutional investors. 60.4% of Aravive shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AraviveN/AN/AN/A-$0.90N/A
Surrozen$7.49MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
AraviveN/A N/A N/A
Surrozen N/A N/A N/A

In the previous week, Surrozen had 1 more articles in the media than Aravive. MarketBeat recorded 1 mentions for Surrozen and 0 mentions for Aravive. Surrozen's average media sentiment score of 1.89 beat Aravive's score of 0.00 indicating that Surrozen is being referred to more favorably in the news media.

Company Overall Sentiment
Aravive Neutral
Surrozen Very Positive

Summary

Surrozen beats Aravive on 3 of the 5 factors compared between the two stocks.

How does Surrozen compare to Atlantic Coastal Acquisition Corp. II?

Surrozen (NASDAQ:SRZNW) and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) are both pharmaceutical products companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, risk, profitability, institutional ownership, media sentiment, earnings and dividends.

In the previous week, Surrozen had 1 more articles in the media than Atlantic Coastal Acquisition Corp. II. MarketBeat recorded 1 mentions for Surrozen and 0 mentions for Atlantic Coastal Acquisition Corp. II. Surrozen's average media sentiment score of 1.89 beat Atlantic Coastal Acquisition Corp. II's score of 0.00 indicating that Surrozen is being referred to more favorably in the media.

Company Overall Sentiment
Surrozen Very Positive
Atlantic Coastal Acquisition Corp. II Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Surrozen$7.49MN/AN/AN/AN/A
Atlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
SurrozenN/A N/A N/A
Atlantic Coastal Acquisition Corp. II N/A N/A N/A

Summary

Surrozen beats Atlantic Coastal Acquisition Corp. II on 3 of the 3 factors compared between the two stocks.

How does Surrozen compare to Avidity Biosciences?

Surrozen (NASDAQ:SRZNW) and Avidity Biosciences (NASDAQ:RNA) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, media sentiment, valuation and earnings.

In the previous week, Avidity Biosciences had 2 more articles in the media than Surrozen. MarketBeat recorded 3 mentions for Avidity Biosciences and 1 mentions for Surrozen. Surrozen's average media sentiment score of 1.89 beat Avidity Biosciences' score of 0.94 indicating that Surrozen is being referred to more favorably in the media.

Company Overall Sentiment
Surrozen Very Positive
Avidity Biosciences Positive

Surrozen has higher earnings, but lower revenue than Avidity Biosciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Surrozen$7.49MN/AN/AN/AN/A
Avidity Biosciences$18.62MN/A-$322.30MN/AN/A

Surrozen has a net margin of 0.00% compared to Avidity Biosciences' net margin of -3,650.39%. Surrozen's return on equity of 0.00% beat Avidity Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
SurrozenN/A N/A N/A
Avidity Biosciences -3,650.39%-44.92%-39.57%

Avidity Biosciences has a consensus price target of $69.42, suggesting a potential upside of 423.14%. Given Avidity Biosciences' stronger consensus rating and higher probable upside, analysts clearly believe Avidity Biosciences is more favorable than Surrozen.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Surrozen
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Avidity Biosciences
1 Sell rating(s)
12 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.32

Summary

Avidity Biosciences beats Surrozen on 6 of the 10 factors compared between the two stocks.

Get Surrozen News Delivered to You Automatically

Sign up to receive the latest news and ratings for SRZNW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SRZNW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SRZNW vs. The Competition

MetricSurrozenBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$458.97M$6.29B$12.40B
Dividend YieldN/A3.86%2.79%5.30%
P/E RatioN/A3.8120.8925.59
Price / SalesN/A7,812.85523.4363.12
Price / CashN/A13.1342.9455.34
Price / BookN/A83.889.866.70
Net IncomeN/A-$96.07M$3.55B$333.77M
7 Day PerformanceN/A0.71%-0.33%0.45%
1 Month PerformanceN/A0.60%1.34%4.06%
1 Year PerformanceN/A70.45%41.10%36.24%

Surrozen Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SRZNW
Surrozen
N/A$0.02
-13.0%
N/A+8.9%$0.00$7.49MN/A80
AIMDW
Ainos
N/A$0.11
flat
N/A-21.3%$0.00$124.16KN/A40
ALVOW
Alvotech
N/A$0.21
-18.2%
N/A-86.0%$0.00$586.32MN/A4
ARAV
Aravive
N/A$0.04
flat
N/AN/A$0.00N/AN/A20
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.00
flat
N/AN/A$0.00N/AN/A15

Related Companies and Tools


This page (NASDAQ:SRZNW) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners